Costa N, et al. - In this retrospective, monocentric, comparative analysis, researchers analyzed 37 TESPAL procedures and 39 embolization procedures to assess the cost-effectiveness of trans-nasal endoscopic sphenopalatine artery ligation (TESPAL) compared to embolization to treat subjects with epistaxis. They reported higher hospitalization costs for embolization as compared to TESPAL ie, 5972 vs 3769 euros. They found a comparative decline of 41% in hospitalization costs with TESPAL treatment. An increase in hospitalization costs by 79% was noted with the presence of comorbidities.